0
Omeprazole - Mopral - Losec Analysis
€149.00
Tax included
OMEPRAZOLE
Laboratory analysis of drugs to certify the presence of Omeprazole and measure the quantity of Omeprazole.
The level of uncertainty of the Omeprazole content analysis depends on the declination selected (Standard <20%, Precise <10% or Regulatory <5%).
Follow the instructions to send your medication to our laboratory for analysis.
Results within 15 working days of receipt of sample.
Omeprazole is a drug used to treat gastric ulcers, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndromes and Helicobacter pylori eradication (in combination with antibiotics).
Omeprazole is the active ingredient in Mopral, marketed by AstraZeneca, as well as numerous generic formulations.
Consuming medicines ordered from dubious or illegal sites can be hazardous to your health. It is essential to check that the online pharmacy is serious and has all the necessary authorizations.
If you have any doubts about the origin of the drug, you should carry out an analysis to certify the presence of the active ingredient and check that its dosage in the drug complies with the indicated content.
Analysis
Omeprazole is analyzed by liquid chromatography coupled with UV-Visible spectrophotometric detection (HPLC-UV Visible).
Chemical name
- Chemical name: 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole
- Chemical Formula: C17H19N3O3S
- CAS number: 73590-58-6
Therapeutic class
- Therapeutic class: Proton pump inhibitor (PPI).
Description of Therapeutic Effects
Omeprazole is used for :
- Treatment of peptic ulcers.
- Gastroesophageal reflux disease (GERD) and erosive esophagitis.
- Zollinger-Ellison syndrome (severe gastric hyperacidity).
- Helicobacter pylori eradication: In association with antibiotics to treat ulcers caused by this bacterium.
Mechanism of action :
- Omeprazole inhibits the proton pump (H+/K+-ATPase) in gastric parietal cells, reducing acid production in the stomach.
Trade names
- Mopral (AstraZeneca).
- Losec (trade name in some countries).
- Various generics under the name Omeprazole.
Main Manufacturers
- AstraZeneca: Main manufacturer of Mopral and Losec.
- Teva Pharmaceuticals: Supplier of generics.
- Sanofi: Manufacturer of PPIs including Omeprazole.
- Mylan: Producer of generics.
OMEPRAZOLE
Specific References
Your drug is analyzed by our expert pharmaceutical analysis laboratory.
The drug to be analyzed must be sent in at least 3 copies in its original packaging (box or vial + blister pack) in order to have all the information.
The drug to be analyzed must be sufficiently protected to avoid any deterioration or damage during transport.
The drug to be analyzed must be accompanied by the completed analysis form.
Documents to download:
The use of counterfeit or illegal medicines (without patent authorisation) presents a proven risk to patients' health:
- Absence of the active ingredient
- Under-dosage of the active ingredient
- Over-dosage of the active ingredient
- Toxic synthetic or degradation impurities
- Presence of another active ingredient
- Toxic excipients
- Presence of toxic residual solvents
- ...
The trade in counterfeit medicines is flourishing and growing exponentially with online trading. The authorities believe that more than half of all medicines sold over the Internet are counterfeit or illegal.
Comments (0)
